NCT01258387View on ClinicalTrials.gov

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2013

Conditions
Heart Failure
Interventions
DRUG

Glial growth factor 2/ Neuregulin 1β3

OTHER

Placebo

Trial Locations (2)

30342

The Medical Group of Saint Joseph's, Atlanta

37232-8802

Vanderbilt University, Nashville

Sponsors
All Listed Sponsors
lead

Acorda Therapeutics

INDUSTRY